L

Lara, R, Mauri, F A, Taylor, H, Derua, R, Shia, A, Gray, C, Nicols, A, Shiner, R J, Schofield, E, Bates, P A, Waelkens, E, Dallman, M, Lamb, J, Zicha, D, Downward, J, Seckl, M J and Pardo, O E (2011) An siRNA screen identifies RSK1 as a key modulator of lung cancer metastasis. Oncogene, 30 (32). pp. 3513-3521. ISSN 1476-5594

S

Schmid, P, Krocker, J, Jehn, C, Michniewicz, K, Lehenbauer-Dehm, S, Eggemann, H, Heilmann, V, Kümmel, S, Schulz, C O, Dieing, A, Wischnewsky, M B, Hauptmann, S, Elling, D, Possinger, K and Flath, B (2005) Primary chemotherapy with gemcitabine as prolonged infusion, non-pegylated liposomal doxorubicin and docetaxel in patients with early breast cancer: final results of a phase II trial. Annals of Oncology, 16 (10). pp. 1624-1631. ISSN 0923-7534

Schmid, Peter, Nagai, Yutaka, Agarwal, Roshan, Hancock, Barry, Savage, Philip M, Sebire, Neil J, Lindsay, Iain, Wells, Michael, Fisher, Rosemary A, Short, Delia, Newlands, Edward S, Wischnewsky, Manfred B and Seckl, Michael J (2009) Prognostic markers and long-term outcome of placental-site trophoblastic tumours: a retrospective observational study. The Lancet, 374 (9683). pp. 48-55. ISSN 0140-6736

Schmid, Peter, Untch, Michael, Kossé, Valentin, Bondar, Grigorij, Vassiljev, Leonid, Tarutinov, Valerie, Lehmann, Ute, Maubach, Lutz, Meurer, Juergen, Wallwiener, Diethelm and Possinger, Kurt (2007) Leuprorelin acetate every-3-months depot versus cyclophosphamide, methotrexate, and fluorouracil as adjuvant treatment in premenopausal patients with node-positive breast cancer: the TABLE study. Journal of Clinical Oncology, 25 (18). pp. 2509-2515. ISSN 1527-7755

Shia, A K H, Gan, G-G, Jairaman, S and Peh, S-C (2005) High frequency of germinal centre derivation in diffuse large B cell lymphoma from Asian patients. Journal of Clinical Pathology, 58 (9). pp. 962-967. ISSN 1472-4146

Syed, Nelofer, Coley, Helen M, Sehouli, Jalid, Koensgen, Dominique, Mustea, Alexander, Szlosarek, Peter, McNeish, Iain, Blagden, Sarah P, Schmid, Peter, Lovell, David P, Hatzimichael, Eleftheria and Crook, Tim (2011) Polo-like kinase Plk2 is an epigenetic determinant of chemosensitivity and clinical outcomes in ovarian cancer. Cancer Research, 71 (9). pp. 3317-3327. ISSN 0008-5472

V

Vella, Viviana (2023) Identification of kinases implicated in temozolomide resistance in glioblastoma. Doctoral thesis (PhD), University of Sussex.